Literature DB >> 25694428

Contributions of unique intracellular domains to switchlike biosensing by Toll-like receptor 4.

Nichole M Daringer1, Kelly A Schwarz1, Joshua N Leonard2.   

Abstract

Toll-like receptors (TLRs) mediate immune recognition of both microbial infections and tissue damage. Aberrant TLR signaling promotes disease; thus, understanding the regulation of TLR signaling is of medical relevance. Although downstream mediators of TLR signaling have been identified, the detailed mechanism by which ligand binding-mediated dimerization induces downstream signaling remains poorly understood. Here, we investigate this question for TLR4, which mediates responsiveness to bacterial LPS and drives inflammatory disease. TLR4 exhibits structural and functional features that are unique among TLRs, including responsiveness to a wide variety of ligands. However, the connection between these structural features and the regulation of signaling is not clear. Here, we investigated how the unique intracellular structures of TLR4 contribute to receptor signaling. Key conclusions include the following. 1) The unique intracellular linker of TLR4 is important for achieving LPS-inducible signaling via Toll/IL-1 receptor (TIR) domain-containing adapter-inducing interferon-β (TRIF) but less so for signaling via myeloid differentiation primary response 88 (MyD88). 2) Membrane-bound TLR4 TIR domains were sufficient to induce signaling. However, introducing long, flexible intracellular linkers neither induced constitutive signaling nor ablated LPS-inducible signaling. Thus, the initiation of TLR4 signaling is regulated by a mechanism that does not require tight geometric constraints. Together, these observations necessitate refining the model of TLR4 signal initiation. We hypothesize that TLR4 may interact with an inhibitory partner in the absence of ligand, via both TIR and extracellular domains of TLR4. In this speculative model, ligand binding induces dissociation of the inhibitory partner, triggering spontaneous, switchlike TIR domain homodimerization to initiate downstream signaling.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Immunology; Receptor Regulation; Receptor Structure-Function; Signal Transduction; Toll-like Receptor 4 (TLR4)

Mesh:

Substances:

Year:  2015        PMID: 25694428      PMCID: PMC4423667          DOI: 10.1074/jbc.M114.610063

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity.

Authors:  Harald Husebye; Øyvind Halaas; Harald Stenmark; Gro Tunheim; Øystein Sandanger; Bjarne Bogen; Andreas Brech; Eicke Latz; Terje Espevik
Journal:  EMBO J       Date:  2006-02-09       Impact factor: 11.598

2.  The GOLD domain-containing protein TMED7 inhibits TLR4 signalling from the endosome upon LPS stimulation.

Authors:  Sarah L Doyle; Harald Husebye; Dympna J Connolly; Terje Espevik; Luke A J O'Neill; Anne F McGettrick
Journal:  Nat Commun       Date:  2012-02-28       Impact factor: 14.919

Review 3.  Assembly and localization of Toll-like receptor signalling complexes.

Authors:  Nicholas J Gay; Martyn F Symmons; Monique Gangloff; Clare E Bryant
Journal:  Nat Rev Immunol       Date:  2014-08       Impact factor: 53.106

4.  Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4.

Authors:  S T Smiley; J A King; W W Hancock
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

5.  Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105.

Authors:  Senad Divanovic; Aurelien Trompette; Sowsan F Atabani; Rajat Madan; Douglas T Golenbock; Alberto Visintin; Robert W Finberg; Alexander Tarakhovsky; Stefanie N Vogel; Yasmine Belkaid; Evelyn A Kurt-Jones; Christopher L Karp
Journal:  Nat Immunol       Date:  2005-04-24       Impact factor: 25.606

Review 6.  TLR-dependent T cell activation in autoimmunity.

Authors:  Kingston H G Mills
Journal:  Nat Rev Immunol       Date:  2011-11-18       Impact factor: 53.106

7.  TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta.

Authors:  Jonathan C Kagan; Tian Su; Tiffany Horng; Amy Chow; Shizuo Akira; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2008-02-24       Impact factor: 25.606

Review 8.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

Review 9.  Toll-Like Receptors and Cancer: MYD88 Mutation and Inflammation.

Authors:  James Q Wang; Yogesh S Jeelall; Laura L Ferguson; Keisuke Horikawa
Journal:  Front Immunol       Date:  2014-07-31       Impact factor: 7.561

Review 10.  Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases.

Authors:  Athina Savva; Thierry Roger
Journal:  Front Immunol       Date:  2013-11-18       Impact factor: 7.561

View more
  3 in total

1.  TRAF3-interacting JNK-activating modulator promotes inflammation by stimulating translocation of Toll-like receptor 4 to lipid rafts.

Authors:  Yehua Li; Jingmin Guan; Wenjia Wang; Chun Hou; Li Zhou; Jian Ma; Yunfeng Cheng; Shi Jiao; Zhaocai Zhou
Journal:  J Biol Chem       Date:  2018-12-20       Impact factor: 5.157

2.  Toll-like receptor 4 signaling: A common pathway for interactions between prooxidants and extracellular disulfide high mobility group box 1 (HMGB1) protein-coupled activation.

Authors:  Yan Zhang; Rajendra Karki; Orisa J Igwe
Journal:  Biochem Pharmacol       Date:  2015-09-12       Impact factor: 5.858

3.  Spatial structure of TLR4 transmembrane domain in bicelles provides the insight into the receptor activation mechanism.

Authors:  Konstantin S Mineev; Sergey A Goncharuk; Marina V Goncharuk; Pavel E Volynsky; Ekaterina V Novikova; Alexander S Aresinev
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.